King's College London

Research portal

The Clinical Relevance of Noncriteria Antiphospholipid Antibodies

Research output: Contribution to journalArticle

Standard

The Clinical Relevance of Noncriteria Antiphospholipid Antibodies. / Bertolaccini, Maria Laura; Sanna, Giovanni.

In: Seminars in Thrombosis and Hemostasis, 03.05.2017.

Research output: Contribution to journalArticle

Harvard

Bertolaccini, ML & Sanna, G 2017, 'The Clinical Relevance of Noncriteria Antiphospholipid Antibodies', Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/s-0037-1601328

APA

Bertolaccini, M. L., & Sanna, G. (2017). The Clinical Relevance of Noncriteria Antiphospholipid Antibodies. Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/s-0037-1601328

Vancouver

Bertolaccini ML, Sanna G. The Clinical Relevance of Noncriteria Antiphospholipid Antibodies. Seminars in Thrombosis and Hemostasis. 2017 May 3. https://doi.org/10.1055/s-0037-1601328

Author

Bertolaccini, Maria Laura ; Sanna, Giovanni. / The Clinical Relevance of Noncriteria Antiphospholipid Antibodies. In: Seminars in Thrombosis and Hemostasis. 2017.

Bibtex Download

@article{9a6ba3643aa443e685d6958165bde72b,
title = "The Clinical Relevance of Noncriteria Antiphospholipid Antibodies",
abstract = "While lupus anticoagulant (LA), anticardiolipin antibodies (aCL), anti-β2 glycoprotein I (anti-β2GPI) antibodies represent the best available and the most widely used tests in the investigation for antiphospholipid syndrome (APS), evidence gathered in recent years indicates that other antiphospholipid antibodies (aPL) specificities may also play a role in the syndrome. Several autoantibodies have been shown to be complexed with phospholipids other than cardiolipin, or to some domains of β2GPI, or else directed to other proteins of the coagulation cascade, and these have also been proposed to be of relevance to APS, and their diagnostic value and clinical utility are the focus of current research.",
keywords = "Journal Article",
author = "Bertolaccini, {Maria Laura} and Giovanni Sanna",
note = "Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.",
year = "2017",
month = "5",
day = "3",
doi = "10.1055/s-0037-1601328",
language = "English",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers",

}

RIS (suitable for import to EndNote) Download

TY - JOUR

T1 - The Clinical Relevance of Noncriteria Antiphospholipid Antibodies

AU - Bertolaccini, Maria Laura

AU - Sanna, Giovanni

N1 - Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

PY - 2017/5/3

Y1 - 2017/5/3

N2 - While lupus anticoagulant (LA), anticardiolipin antibodies (aCL), anti-β2 glycoprotein I (anti-β2GPI) antibodies represent the best available and the most widely used tests in the investigation for antiphospholipid syndrome (APS), evidence gathered in recent years indicates that other antiphospholipid antibodies (aPL) specificities may also play a role in the syndrome. Several autoantibodies have been shown to be complexed with phospholipids other than cardiolipin, or to some domains of β2GPI, or else directed to other proteins of the coagulation cascade, and these have also been proposed to be of relevance to APS, and their diagnostic value and clinical utility are the focus of current research.

AB - While lupus anticoagulant (LA), anticardiolipin antibodies (aCL), anti-β2 glycoprotein I (anti-β2GPI) antibodies represent the best available and the most widely used tests in the investigation for antiphospholipid syndrome (APS), evidence gathered in recent years indicates that other antiphospholipid antibodies (aPL) specificities may also play a role in the syndrome. Several autoantibodies have been shown to be complexed with phospholipids other than cardiolipin, or to some domains of β2GPI, or else directed to other proteins of the coagulation cascade, and these have also been proposed to be of relevance to APS, and their diagnostic value and clinical utility are the focus of current research.

KW - Journal Article

U2 - 10.1055/s-0037-1601328

DO - 10.1055/s-0037-1601328

M3 - Article

C2 - 28470650

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

ER -

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454